<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/07CBF307-4B85-4A66-BD62-CDD846F8AFC9"><gtr:id>07CBF307-4B85-4A66-BD62-CDD846F8AFC9</gtr:id><gtr:name>Scottish School of Primary Care SSPC</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6970B7FB-E221-4A78-80CB-AF2591347373"><gtr:id>6970B7FB-E221-4A78-80CB-AF2591347373</gtr:id><gtr:name>Scottish Mental Health Research Network (SMHRN)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>School of Clinical Sciences</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/07CBF307-4B85-4A66-BD62-CDD846F8AFC9"><gtr:id>07CBF307-4B85-4A66-BD62-CDD846F8AFC9</gtr:id><gtr:name>Scottish School of Primary Care SSPC</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6970B7FB-E221-4A78-80CB-AF2591347373"><gtr:id>6970B7FB-E221-4A78-80CB-AF2591347373</gtr:id><gtr:name>Scottish Mental Health Research Network (SMHRN)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/9C07C26D-E78C-4FB7-AC7A-4B5FAC161A1E"><gtr:id>9C07C26D-E78C-4FB7-AC7A-4B5FAC161A1E</gtr:id><gtr:firstName>Steff</gtr:firstName><gtr:surname>Lewis</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/9DB71E5D-F59A-48C9-9A38-20594C65AD77"><gtr:id>9DB71E5D-F59A-48C9-9A38-20594C65AD77</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:surname>Sandercock</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/E17F12AB-A263-48AE-A6EE-C3D8B8F78111"><gtr:id>E17F12AB-A263-48AE-A6EE-C3D8B8F78111</gtr:id><gtr:firstName>Gordon</gtr:firstName><gtr:otherNames>Douglas</gtr:otherNames><gtr:surname>Murray</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/5C50342E-38B8-4923-87E8-9220D818D4A0"><gtr:id>5C50342E-38B8-4923-87E8-9220D818D4A0</gtr:id><gtr:firstName>Malcolm</gtr:firstName><gtr:otherNames>Robert</gtr:otherNames><gtr:surname>Macleod</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/646B40A0-06CE-4FA0-9985-16132FA25DCB"><gtr:id>646B40A0-06CE-4FA0-9985-16132FA25DCB</gtr:id><gtr:firstName>Aziz</gtr:firstName><gtr:surname>Sheikh</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/AD137D73-1BB7-4E29-ABE7-233EE06C47AD"><gtr:id>AD137D73-1BB7-4E29-ABE7-233EE06C47AD</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:surname>Sharpe</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/1E9ED8CE-0D66-4BCB-8CC9-91B5A698F8BA"><gtr:id>1E9ED8CE-0D66-4BCB-8CC9-91B5A698F8BA</gtr:id><gtr:firstName>Stuart</gtr:firstName><gtr:surname>Ralston</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0800803"><gtr:id>4FB8C499-2A71-4BE2-BB34-8FE2748B4BD4</gtr:id><gtr:title>Edinburgh Trials Methodology Hub</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0800803</gtr:grantReference><gtr:abstractText>When a new drug is being developed it passes through several stages of development. After the initial preclinical development, first in man studies evaluate the safety and potential side effects. Then explanatory studies optimise the treatment, for example in terms of which patients have the greatest potential to benefit and what dose to use. Such studies look at underlying disease mechanisms, and test whether an intervention has the potential to be useful in practice. Then pragmatic studies test whether any potential benefit seen in the explanatory trials can be realised in clinical practice. For non-drug treatments the terminology is different, but the development path is similar.

There are many reasons why an intervention can fail as it progresses through the stages of development, and the aim of the Edinburgh Trials Methodology Hub is to undertake a programme of research which will help to increase the chances of success at each step of the development process. We shall attempt to learn lessons both from successful development programmes and also from others which have failed.

This will be achieved by encouraging interdisciplinary cllaboration between the scientists who are working on understanding underlying disease mechanisms and those with experience in clinical trials methodology. The end results will be to improve the design and analysis of future clinical trials, and to provide researchers with trials support and access to genetic and imaging technologies to identify patient subgroups with the greatest potential to benefit within ongoing trials.</gtr:abstractText><gtr:technicalSummary>Our vision is to deliver more effective translation of novel scientific ideas and discoveries (both drug and non-drug) into innovative clinical practice. A major challenge in clinical medicine is to identify therapeutic interventions that can be targeted to the correct patient at the right time to substantially improve disease outcomes. Traditionally, clinical trial design has focussed on delivering a standardised intervention on a large scale to patients with a specific clinical presentation which may actually have several different underlying causes, in terms of pathophysiology. This approach has been successful to an extent, but often these interventions have modest effects for the individual patient. Ideally therefore, one would wish to develop biomarkers which can be used in clinical practice to predict which patients will have the greatest response to an intervention, whilst excluding those who are likely to respond poorly or not at all. The vision of the Edinburgh Clinical Trials Methodology Hub will be to develop technologies to achieve this aim, by exploiting knowledge gained from animal models; by developing grid based networks for image analysis and processing; by exploiting access to genomic technologies and by developing a facility for secondary analysis of existing data to develop and validate prognostic models. The end result will be to improve the design of future clinical trials and to provide researchers access to imaging and genetic technologies to identify patient subgroups who respond best within ongoing trials.

In parallel with the planned methodological developments, the Edinburgh Hub will develop a training programme which combines elements of existing programmes in translational medicine, molecular medicine and public health sciences to develop the next generation of trialists and methodologists.</gtr:technicalSummary><gtr:fund><gtr:end>2013-12-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>2213022</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Edinburgh Clinical Trials Unit</gtr:department><gtr:description>Edinburgh Clinical Trials Unit</gtr:description><gtr:id>B426CDCF-14DE-401E-B026-BC466451DBDC</gtr:id><gtr:impact>The principal outputs to date have been grant applications for clinical trials which have been funded - including awards through MRC EME, Arthritis Research UK, and CSO.</gtr:impact><gtr:outcomeId>5AB9F263E9D-1</gtr:outcomeId><gtr:partnerContribution>The collaboration has been a source of research questions for the Merthodology Hub and given the opportunity to evaluate and promote methodological developments emerging from the Methodology Hub.</gtr:partnerContribution><gtr:piContribution>The senior statisticians with the Hub work closely with the Trials Unit, giving statistical input for trial protocols and grant applications.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Scottish Mental Health Research Network (SMHRN)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Scottish Mental Health Research Network</gtr:description><gtr:id>A8CCAC13-1630-42B9-AB18-49F6DE88793B</gtr:id><gtr:impact>The outputs to date have been grant applications being worked up for submission.</gtr:impact><gtr:outcomeId>7DB0B8159B9-1</gtr:outcomeId><gtr:partnerContribution>The protocols developed via the SMHRN provide a source of methodological research problemsand also a testbed for methodological innovations.</gtr:partnerContribution><gtr:piContribution>Hub statisticians are involved in giving statistical advice to researchers via the SMHRN's Protocol Development Groups.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Scottish School of Primary Care SSPC</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Scottish eHealth Informatics Research Centre</gtr:department><gtr:description>Scottish eHealth Informatics Research Centre</gtr:description><gtr:id>FB528966-F793-4392-AAE7-132B1F4132B2</gtr:id><gtr:impact>It is too early for this collaboration to have produced outputs</gtr:impact><gtr:outcomeId>eN4pnKGsfH5-1</gtr:outcomeId><gtr:partnerContribution>Sheikh is a grant holder for the eHIRC. The grant application to extend the Hub funding beyond 2013 has eHealth as a major research theme.</gtr:partnerContribution><gtr:piContribution>This is at a very early stage, with the eHIRC just having been funded.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>834329</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Medical Research Council Clinician Scientist Fellowship</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>E29F52B9-C7A6-4284-A5FA-BE81F40777BA</gtr:id><gtr:outcomeId>geJPwhcdGT50</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>47030</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Chief Scientist Office (CSO)</gtr:description><gtr:fundingOrg>Chief Scientist Office (CSO)</gtr:fundingOrg><gtr:id>50E6E59C-7717-46E4-A8B9-43DC7CE201ED</gtr:id><gtr:outcomeId>ApWJX6iQk3h0</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>756791</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Arthritis Research UK</gtr:description><gtr:end>2013-06-02</gtr:end><gtr:fundingOrg>Arthritis Research UK</gtr:fundingOrg><gtr:id>7B0D1A12-0A49-4741-8EAF-8AC7EAEFD96B</gtr:id><gtr:outcomeId>UtYgs8nZQcq0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>485908</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Health Technology Assessment Programme (HTA)</gtr:department><gtr:description>NIHR HTA</gtr:description><gtr:end>2013-08-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>52E27A02-8E05-4BEB-B0B1-3377F44CAB1E</gtr:id><gtr:outcomeId>Fj6WVK4GmZD0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>120000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Methodology Research Panel</gtr:description><gtr:end>2012-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>840503BA-F236-4F0B-A92D-E6CA216739EF</gtr:id><gtr:outcomeId>34A0136268C0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>834329</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Clinician Scientist Fellowship</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G0902303/95197</gtr:fundingRef><gtr:id>AB13C474-1881-491A-8284-26A72376F64C</gtr:id><gtr:outcomeId>Gpm5squHgNV</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Efficacy and Mechanism Evaluation Programme (EME)</gtr:description><gtr:end>2014-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>1F9A9B13-46F0-46CC-9CB7-681AE9A74418</gtr:id><gtr:outcomeId>EDA98B5C0020</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2140000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>HTA Programme</gtr:description><gtr:end>2017-05-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:fundingRef>11/01/1930</gtr:fundingRef><gtr:id>BA5703DC-59B6-43CD-A51A-72596B4C2B50</gtr:id><gtr:outcomeId>cvtBnvhdy8H</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>224999</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CSO funding Health Services Research</gtr:description><gtr:end>2013-03-02</gtr:end><gtr:fundingOrg>Chief Scientist Office (CSO)</gtr:fundingOrg><gtr:id>A0618929-B138-4FB2-9623-6C99DE81B381</gtr:id><gtr:outcomeId>YWmxEsWYHhx0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3070000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EME Programme</gtr:description><gtr:end>2014-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>D5C5FBA3-1650-4277-9549-FBE877196479</gtr:id><gtr:outcomeId>ixFk4EhcMeD</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2940842</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Health Technology Assessment Programme (HTA)</gtr:department><gtr:description>NIHR HTA</gtr:description><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>CF34F70F-146F-4A53-AE98-8BC2F6B2B5AB</gtr:id><gtr:outcomeId>o5TfaPnnqu90</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1340000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2018-05-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:fundingRef>SP/12/2/29422</gtr:fundingRef><gtr:id>4737AB39-4E7A-4495-8788-AAE8411B44ED</gtr:id><gtr:outcomeId>n3Z7F8rxpTk</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1369437</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC NIHR</gtr:description><gtr:end>2016-04-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>77B5628C-EB96-47D1-B7EA-F4B72FB1878C</gtr:id><gtr:outcomeId>WyDmfUTZ87a0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>723692</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Arthritis Research UK</gtr:description><gtr:end>2016-02-02</gtr:end><gtr:fundingOrg>Arthritis Research UK</gtr:fundingOrg><gtr:id>2E3801BD-8B64-4CD0-B097-2C0BC1DD8F2F</gtr:id><gtr:outcomeId>nZoQgECTaun0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>400000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CSO funding Health Sevices Research</gtr:description><gtr:end>2012-04-02</gtr:end><gtr:fundingOrg>Chief Scientist Office (CSO)</gtr:fundingOrg><gtr:id>BC2965B4-677A-4D93-AAB2-E5B75FF63BF6</gtr:id><gtr:outcomeId>0FAA82091CD0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>A number of methodological studies, now supported by relevant publications, have demonstrated the strengths and limitations of ordinal analysis in clinical trials of head injury and stroke.</gtr:description><gtr:id>869119C2-1088-4435-BEBC-6918C5102346</gtr:id><gtr:impact>An ordinal approach has been adopted as the primary analytical approach in a number of on-going clinical trials.</gtr:impact><gtr:outcomeId>jPTmMRhe9xc</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Ordinal Analysis of Clinical Trial Outcomes</gtr:title><gtr:type>Data analysis technique</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>BD410FF5-CA8D-4585-9490-E24F20666428</gtr:id><gtr:title>Effectiveness of telemonitoring integrated into existing clinical services on hospital admission for exacerbation of chronic obstructive pulmonary disease: researcher blind, multicentre, randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e2678fb12fa345608553454448606d1b"><gtr:id>e2678fb12fa345608553454448606d1b</gtr:id><gtr:otherNames>Pinnock H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>543e944546dd09.32368211</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>24C3EAB4-C727-42E8-AE34-F55A7B1320FE</gtr:id><gtr:title>Practical methodological strategies for individual patient data systematic reviews</gtr:title><gtr:parentPublicationTitle>The Lancet</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7caf08ea521ae8777e689866dc68cf39"><gtr:id>7caf08ea521ae8777e689866dc68cf39</gtr:id><gtr:otherNames>Crawford F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>543e9443bafd31.78226229</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B2B9D7D2-FCF8-4446-A931-37E7A8EFC5B5</gtr:id><gtr:title>Disease-specific health-related quality of life (HRQL) instruments for food allergy: protocol for a systematic review.</gtr:title><gtr:parentPublicationTitle>Clinical and translational allergy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5557ecd1dc17f5f14cab9ac0b2efca4"><gtr:id>b5557ecd1dc17f5f14cab9ac0b2efca4</gtr:id><gtr:otherNames>Salvilla SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2045-7022</gtr:issn><gtr:outcomeId>543e94479ba796.78444247</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8059AF37-DF16-419C-81F4-0A5F0B0EE7AF</gtr:id><gtr:title>Can clinical features distinguish between immobile patients with stroke at high and low risk of deep vein thrombosis? Statistical modelling based on the CLOTS trials cohorts.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8a64354cef682d91105e2c9e80246794"><gtr:id>8a64354cef682d91105e2c9e80246794</gtr:id><gtr:otherNames>Dennis M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>qdCWRC7hx9X</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA79CC4B-83DA-424E-BCB8-2D2B267B61E0</gtr:id><gtr:title>Effect of alteplase within 6 hours of acute ischemic stroke on all-cause mortality (third International Stroke Trial).</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f67a36f4c44c4922a18eaf376974507b"><gtr:id>f67a36f4c44c4922a18eaf376974507b</gtr:id><gtr:otherNames>Whiteley WN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn><gtr:outcomeId>5675dc94924a1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>84E13F31-A9C0-46D1-84EF-4CE090C0CF93</gtr:id><gtr:title>The added value of ordinal analysis in clinical trials: an example in traumatic brain injury.</gtr:title><gtr:parentPublicationTitle>Critical care (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/58817ae986e78252e679b5980b439ab3"><gtr:id>58817ae986e78252e679b5980b439ab3</gtr:id><gtr:otherNames>Roozenbeek B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1364-8535</gtr:issn><gtr:outcomeId>Jk71q3R8R3L</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>365C56E6-CF9C-4CCA-B620-04542BCA7927</gtr:id><gtr:title>Predictors of upper limb recovery after stroke: a systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>Clinical rehabilitation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4b8a8bdf95d1885931db88e1d3df732"><gtr:id>a4b8a8bdf95d1885931db88e1d3df732</gtr:id><gtr:otherNames>Coupar F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0269-2155</gtr:issn><gtr:outcomeId>pm_12896_26_22023891</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>07AEA2DD-12A7-4960-8D9A-EBAC6CD610B8</gtr:id><gtr:title>Age of transfused blood in critically ill adults.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/96169b9537fe197692d023099265bad7"><gtr:id>96169b9537fe197692d023099265bad7</gtr:id><gtr:otherNames>Lacroix J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>56af3effad74e0.60301740</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E03C52F4-C012-4D5B-B5AB-37AAE075E19E</gtr:id><gtr:title>Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/27d92ef546ea273952a7cfddeb17749e"><gtr:id>27d92ef546ea273952a7cfddeb17749e</gtr:id><gtr:otherNames>Emberson J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>54524fe1c9a270.52727132</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1EB512BD-B3BC-49DE-8A53-E1FBDE674F09</gtr:id><gtr:title>A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosis.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/22f4b0c676241659342f5bf9f5c2ce79"><gtr:id>22f4b0c676241659342f5bf9f5c2ce79</gtr:id><gtr:otherNames>Alton EW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>doi_12896_013_203309</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>48530E52-C758-4ABB-8E6A-EDECDA507DAA</gtr:id><gtr:title>Neurology out-patients with symptoms unexplained by disease: illness beliefs and financial benefits predict 1-year outcome.</gtr:title><gtr:parentPublicationTitle>Psychological medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/af279763f6cdfe6575e4b958710f21ea"><gtr:id>af279763f6cdfe6575e4b958710f21ea</gtr:id><gtr:otherNames>Sharpe M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0033-2917</gtr:issn><gtr:outcomeId>JxLJtUVMLuH</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41199B3B-A2AE-4B45-B5D7-675895955FFC</gtr:id><gtr:title>Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5-year results.</gtr:title><gtr:parentPublicationTitle>BJOG : an international journal of obstetrics and gynaecology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4cb1900639c08bae09f0c6fa2d5c5d60"><gtr:id>4cb1900639c08bae09f0c6fa2d5c5d60</gtr:id><gtr:otherNames>Moss JG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1470-0328</gtr:issn><gtr:outcomeId>htZtH9CQgU4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>430991E2-8B35-456D-A88B-DF6CD567C16E</gtr:id><gtr:title>The effects of uterine artery embolisation and surgical treatment on ovarian function in women with uterine fibroids.</gtr:title><gtr:parentPublicationTitle>BJOG : an international journal of obstetrics and gynaecology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/97aafcc886ab2be03402a97e61dc2c6c"><gtr:id>97aafcc886ab2be03402a97e61dc2c6c</gtr:id><gtr:otherNames>Rashid S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1470-0328</gtr:issn><gtr:outcomeId>T3xzGReDzY1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E6779CC-3508-483C-A178-3F5324BAB91F</gtr:id><gtr:title>A simulation study evaluating approaches to the analysis of ordinal outcome data in randomized controlled trials in traumatic brain injury: results from the IMPACT Project.</gtr:title><gtr:parentPublicationTitle>Clinical trials (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1c23c85bbf3d8b086137667e9560595a"><gtr:id>1c23c85bbf3d8b086137667e9560595a</gtr:id><gtr:otherNames>McHugh GS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1740-7745</gtr:issn><gtr:outcomeId>XjhbfA4AGjk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6387BA7-616C-4067-B7E8-FF1C2F3FED9F</gtr:id><gtr:title>Pain in patients attending a specialist cancer service: prevalence and association with emotional distress.</gtr:title><gtr:parentPublicationTitle>Journal of pain and symptom management</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fcfe5fea0c084750c4184210cf1682a7"><gtr:id>fcfe5fea0c084750c4184210cf1682a7</gtr:id><gtr:otherNames>O'Connor M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0885-3924</gtr:issn><gtr:outcomeId>pm_12896_26_21680140</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B5862702-228D-4C9D-987E-B23A2C1AF9DE</gtr:id><gtr:title>Development and validation of an ankle brachial index risk model for the prediction of cardiovascular events.</gtr:title><gtr:parentPublicationTitle>European journal of preventive cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a07b16b8b420279616eb1441faac88ea"><gtr:id>a07b16b8b420279616eb1441faac88ea</gtr:id><gtr:otherNames>Fowkes FG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2047-4873</gtr:issn><gtr:outcomeId>54525311996c92.61883934</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC836D53-8B38-4030-93BB-56716ABC8103</gtr:id><gtr:title>Randomized Double-Blind Trial of Pregabalin Versus Placebo in Conjunction With Palliative Radiotherapy for Cancer-Induced Bone Pain.</gtr:title><gtr:parentPublicationTitle>Journal of clinical oncology : official journal of the American Society of Clinical Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6434c97f6fba91ba89f3da369b9814da"><gtr:id>6434c97f6fba91ba89f3da369b9814da</gtr:id><gtr:otherNames>Fallon M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0732-183X</gtr:issn><gtr:outcomeId>56af3efd193ac9.25798663</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>61390EC4-2304-4BE5-8DF8-5E5067E5BF73</gtr:id><gtr:title>Large between-center differences in outcome after moderate and severe traumatic brain injury in the international mission on prognosis and clinical trial design in traumatic brain injury (IMPACT) study.</gtr:title><gtr:parentPublicationTitle>Neurosurgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0d1d81d86ec3031057d15ddf62f6005b"><gtr:id>0d1d81d86ec3031057d15ddf62f6005b</gtr:id><gtr:otherNames>Lingsma HF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0148-396X</gtr:issn><gtr:outcomeId>TsQvxqiKk6t</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>343B9D55-DBDB-42E3-971D-1B1F6F5F12FE</gtr:id><gtr:title>Systematic review of head cooling in adults after traumatic brain injury and stroke.</gtr:title><gtr:parentPublicationTitle>Health technology assessment (Winchester, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d825861c952acabcba90435f144359d"><gtr:id>4d825861c952acabcba90435f144359d</gtr:id><gtr:otherNames>Harris B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1366-5278</gtr:issn><gtr:outcomeId>pm_12896_26_23171713</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78ECE125-06EF-4693-81A4-DE0352DA722F</gtr:id><gtr:title>Alteplase for acute ischemic stroke: outcomes by clinically important subgroups in the Third International Stroke Trial.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/53eb0e856a7f3b3e6ce1c14558548cda"><gtr:id>53eb0e856a7f3b3e6ce1c14558548cda</gtr:id><gtr:otherNames>Lindley RI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn><gtr:outcomeId>56af3f0031e3d8.10731344</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C35F82CF-0AA1-4FA9-B2E2-BDDA320B168A</gtr:id><gtr:title>Genetic variants associated with altered plasma levels of C-reactive protein are not associated with late-life cognitive ability in four Scottish samples.</gtr:title><gtr:parentPublicationTitle>Behavior genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/92c807dd74c086f13d2174d70fc9bf1c"><gtr:id>92c807dd74c086f13d2174d70fc9bf1c</gtr:id><gtr:otherNames>Marioni RE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0001-8244</gtr:issn><gtr:outcomeId>nUme8289RLG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>73FBED74-ED44-477C-9438-8A5EF7E11AF1</gtr:id><gtr:title>Systematic review and stratified meta-analysis of the efficacy of RhoA and Rho kinase inhibitors in animal models of ischaemic stroke.</gtr:title><gtr:parentPublicationTitle>Systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/afccff65ae6e6b0c0845b76d65cc6180"><gtr:id>afccff65ae6e6b0c0845b76d65cc6180</gtr:id><gtr:otherNames>Vesterinen HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2046-4053</gtr:issn><gtr:outcomeId>543e9447c6d6e3.03783922</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06BADB94-A23B-4E41-A169-B5781BA8D3E4</gtr:id><gtr:title>Effect of thrombolysis with alteplase within 6 h of acute ischaemic stroke on long-term outcomes (the third International Stroke Trial [IST-3]): 18-month follow-up of a randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/12c7afbed82d8caa4bccf507dbc328ea"><gtr:id>12c7afbed82d8caa4bccf507dbc328ea</gtr:id><gtr:otherNames>IST-3 collaborative group</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>543e9443e8e579.84507716</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2528E1EF-81A1-4B21-9A4F-1B31797A4D61</gtr:id><gtr:title>Inflammatory markers and poor outcome after stroke: a prospective cohort study and systematic review of interleukin-6.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e0e5e9cd102979ad42c3c043c5c1088d"><gtr:id>e0e5e9cd102979ad42c3c043c5c1088d</gtr:id><gtr:otherNames>Whiteley W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>g5Lg6CFa5fm</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6965879E-22F2-4D60-A01E-468799EB2D77</gtr:id><gtr:title>Prevalence, associations, and adequacy of treatment of major depression in patients with cancer: a cross-sectional analysis of routinely collected clinical data.</gtr:title><gtr:parentPublicationTitle>The lancet. Psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a3aabcaa9fd883d77d7401fb9ae5630"><gtr:id>5a3aabcaa9fd883d77d7401fb9ae5630</gtr:id><gtr:otherNames>Walker J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2215-0366</gtr:issn><gtr:outcomeId>56af3efe2ad864.72786730</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DE097686-1167-4E4D-B262-1E423A7C33B3</gtr:id><gtr:title>Genetic variation in the TNFRSF11A gene encoding RANK is associated with susceptibility to Paget's disease of bone.</gtr:title><gtr:parentPublicationTitle>Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1fdd211cb1bcbe1e552b0738ad31f85c"><gtr:id>1fdd211cb1bcbe1e552b0738ad31f85c</gtr:id><gtr:otherNames>Chung PY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0884-0431</gtr:issn><gtr:outcomeId>VemjtXhQXLf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9CF004CE-A6BF-4368-A4A5-DB60E672C9FB</gtr:id><gtr:title>No evidence of bias in the process of publication of diagnostic accuracy studies in stroke submitted as abstracts.</gtr:title><gtr:parentPublicationTitle>Journal of clinical epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b60e1b66dea5c8f00239c716ba13287"><gtr:id>8b60e1b66dea5c8f00239c716ba13287</gtr:id><gtr:otherNames>Brazzelli M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0895-4356</gtr:issn><gtr:outcomeId>GsWesoTcfUh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A541AF8-266E-434F-84CA-DAA1DBB260E7</gtr:id><gtr:title>Cost-effectiveness of combining systematic identification and treatment of co-morbid major depression for people with chronic diseases: the example of cancer.</gtr:title><gtr:parentPublicationTitle>Psychological medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/271c0eeb7e850a7a6170ae27080c3efc"><gtr:id>271c0eeb7e850a7a6170ae27080c3efc</gtr:id><gtr:otherNames>Walker S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0033-2917</gtr:issn><gtr:outcomeId>545251ebac2914.45980418</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BDEEC5F2-EE18-4309-A15E-E1BB139FA7F1</gtr:id><gtr:title>Population-based trends in pregnancy hypertension and pre-eclampsia: an international comparative study.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7c1ca5d19d77bf86fc89c33a95341b7a"><gtr:id>7c1ca5d19d77bf86fc89c33a95341b7a</gtr:id><gtr:otherNames>Roberts CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>a4eLidmRSgk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>768716CB-1AA3-4B44-8C3B-EEB14CF55C1A</gtr:id><gtr:title>Targeting aspirin in acute disabling ischemic stroke: an individual patient data meta-analysis of three large randomized trials.</gtr:title><gtr:parentPublicationTitle>International journal of stroke : official journal of the International Stroke Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d21a9944b6062ae4454025970fd10809"><gtr:id>d21a9944b6062ae4454025970fd10809</gtr:id><gtr:otherNames>Thompson DD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1747-4930</gtr:issn><gtr:outcomeId>5675e2385cbfc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BE94E3F4-FFAE-4921-AC99-3E07B2ABD85C</gtr:id><gtr:title>Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aebe6039cfa9ba1edd91fdcf3c128eb4"><gtr:id>aebe6039cfa9ba1edd91fdcf3c128eb4</gtr:id><gtr:otherNames>Mendelow AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>pm_12896_26_23726393</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F4CB831-B9BA-4992-BAF1-6E75C5B05623</gtr:id><gtr:title>Peripheral levels of fibrinogen, C-reactive protein, and plasma viscosity predict future cognitive decline in individuals without dementia.</gtr:title><gtr:parentPublicationTitle>Psychosomatic medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/92c807dd74c086f13d2174d70fc9bf1c"><gtr:id>92c807dd74c086f13d2174d70fc9bf1c</gtr:id><gtr:otherNames>Marioni RE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0033-3174</gtr:issn><gtr:outcomeId>B193EA9E002</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A418E16C-4E27-4819-8F14-73BE91E731C6</gtr:id><gtr:title>MRI using ultrasmall superparamagnetic particles of iron oxide in patients under surveillance for abdominal aortic aneurysms to predict rupture or surgical repair: MRI for abdominal aortic aneurysms to predict rupture or surgery-the MA(3)RS study.</gtr:title><gtr:parentPublicationTitle>Open heart</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/30dabe710a3956cc31230c9449e8c478"><gtr:id>30dabe710a3956cc31230c9449e8c478</gtr:id><gtr:otherNames>McBride OM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2053-3624</gtr:issn><gtr:outcomeId>56af3eff3fc4d9.32796516</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF8B3DD0-F3F0-4724-923F-A6E47846CB7F</gtr:id><gtr:title>Genetic associations between fibrinogen and cognitive performance in three Scottish cohorts.</gtr:title><gtr:parentPublicationTitle>Behavior genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/92c807dd74c086f13d2174d70fc9bf1c"><gtr:id>92c807dd74c086f13d2174d70fc9bf1c</gtr:id><gtr:otherNames>Marioni RE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0001-8244</gtr:issn><gtr:outcomeId>pm_12896_26_21258858</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FE2503AC-B089-4F2C-BEEC-5206A2006566</gtr:id><gtr:title>Prevalence, management, and outcomes of critically ill patients with prothrombin time prolongation in United Kingdom intensive care units.</gtr:title><gtr:parentPublicationTitle>Critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f9b90c3bc89a25541abb71483af4e188"><gtr:id>f9b90c3bc89a25541abb71483af4e188</gtr:id><gtr:otherNames>Walsh TS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0090-3493</gtr:issn><gtr:outcomeId>DJaGjFXSsTm</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DFF68BC6-F166-4333-BF1F-6E6FBC10DFE6</gtr:id><gtr:title>Culturally adapting the prevention of diabetes and obesity in South Asians (PODOSA) trial.</gtr:title><gtr:parentPublicationTitle>Health promotion international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/392a2bd544fcd08dde6d8b105f5f263e"><gtr:id>392a2bd544fcd08dde6d8b105f5f263e</gtr:id><gtr:otherNames>Wallia S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0957-4824</gtr:issn><gtr:outcomeId>doi_12896_pro_dat015</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93889861-0E3D-4423-B410-E00DFCFBDE30</gtr:id><gtr:title>Making randomised trials more efficient: report of the first meeting to discuss the Trial Forge platform.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59fac098248b340aabd71315601019f7"><gtr:id>59fac098248b340aabd71315601019f7</gtr:id><gtr:otherNames>Treweek S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>5675e5e643ade</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38436A44-F795-4DE0-9ED5-2C00BECD3ADA</gtr:id><gtr:title>Comparison of statistical and clinical predictions of functional outcome after ischemic stroke.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d21a9944b6062ae4454025970fd10809"><gtr:id>d21a9944b6062ae4454025970fd10809</gtr:id><gtr:otherNames>Thompson DD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>543e94485b1a15.88657373</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E0E6A3F1-24A3-4D26-89A8-92D8AE95D386</gtr:id><gtr:title>Comment on &amp;quot;Ccl2, Cx3cr1 and Ccl2/Cx3cr1 chemokine deficiencies are not sufficient to cause age-related retinal degeneration&amp;quot; by Luhmann et&amp;nbsp;al. (Exp. Eye Res. 2013; 107: 80.doi: 10.1016).</gtr:title><gtr:parentPublicationTitle>Experimental eye research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/05c3af20fb3b55847ec9e0e9ba85b575"><gtr:id>05c3af20fb3b55847ec9e0e9ba85b575</gtr:id><gtr:otherNames>Combadi?re C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0014-4835</gtr:issn><gtr:outcomeId>doi_12896_013_10_015</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>20D224F1-DCBF-478F-8ABF-69E890CED6A0</gtr:id><gtr:title>Blood biomarkers for the diagnosis of acute cerebrovascular diseases: a prospective cohort study.</gtr:title><gtr:parentPublicationTitle>Cerebrovascular diseases (Basel, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e0e5e9cd102979ad42c3c043c5c1088d"><gtr:id>e0e5e9cd102979ad42c3c043c5c1088d</gtr:id><gtr:otherNames>Whiteley W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1015-9770</gtr:issn><gtr:outcomeId>pm_12896_26_21778711</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1CAD5C6-B7A0-48CA-8BEE-E2E5E763E785</gtr:id><gtr:title>A systematic review of clinical trials of pharmacological interventions for acute ischaemic stroke (1955-2008) that were completed, but not published in full.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d5d3da7805e7ba8945127c1533ecb04"><gtr:id>5d5d3da7805e7ba8945127c1533ecb04</gtr:id><gtr:otherNames>Gibson LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>a7mSfKZ2aTc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>10ED94FF-B343-48B0-AB3E-2BC658A87DFB</gtr:id><gtr:title>Monitoring symptoms at home: what methods would cancer patients be comfortable using?</gtr:title><gtr:parentPublicationTitle>Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d4c1a06f636bf2d7091db8f305a4527f"><gtr:id>d4c1a06f636bf2d7091db8f305a4527f</gtr:id><gtr:otherNames>Kleiboer A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0962-9343</gtr:issn><gtr:outcomeId>jNigHPPsbdo</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D178C8E6-1842-4787-A515-735113C4E01C</gtr:id><gtr:title>A randomized, controlled trial of simvastatin versus rosuvastatin in patients with acute myocardial infarction: the Secondary Prevention of Acute Coronary Events--Reduction of Cholesterol to Key European Targets Trial.</gtr:title><gtr:parentPublicationTitle>European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology &amp; Prevention and Cardiac Rehabilitation and Exercise Physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f03e4a4615b3e85bdde54ec30a0440d"><gtr:id>6f03e4a4615b3e85bdde54ec30a0440d</gtr:id><gtr:otherNames>Hall AS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1741-8267</gtr:issn><gtr:outcomeId>b4cPeyiKw97</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>04A9EAF2-3E40-48BA-8F55-BD125E28BC39</gtr:id><gtr:title>Trial Steering Committees in randomised controlled trials: A survey of registered clinical trials units to establish current practice and experiences.</gtr:title><gtr:parentPublicationTitle>Clinical trials (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a328dde90a8c07550067687ea668cc31"><gtr:id>a328dde90a8c07550067687ea668cc31</gtr:id><gtr:otherNames>Conroy EJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1740-7745</gtr:issn><gtr:outcomeId>56af3d40cb5b23.73084575</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F3E1E1AF-1BC1-4371-AA55-45986A656B03</gtr:id><gtr:title>The timing, extent, progression and regression of deep vein thrombosis in immobile stroke patients: observational data from the CLOTS multicenter randomized trials.</gtr:title><gtr:parentPublicationTitle>Journal of thrombosis and haemostasis : JTH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8a64354cef682d91105e2c9e80246794"><gtr:id>8a64354cef682d91105e2c9e80246794</gtr:id><gtr:otherNames>Dennis M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1538-7836</gtr:issn><gtr:outcomeId>pm_12896_26_21883879</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>916CAD67-AB98-43A0-A7A8-881F8247D3FC</gtr:id><gtr:title>Noninvasive MRI measurement of CBF: evaluating an arterial spin labelling sequence with 99mTc-HMPAO CBF autoradiography in a rat stroke model.</gtr:title><gtr:parentPublicationTitle>Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b8ad1c7bf4016ad7b98d2c50dc7946d6"><gtr:id>b8ad1c7bf4016ad7b98d2c50dc7946d6</gtr:id><gtr:otherNames>Baskerville TA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0271-678X</gtr:issn><gtr:outcomeId>pm_12896_26_22472604</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D82BBA5-FD9F-4A49-B8F4-FAC4E41E6BD7</gtr:id><gtr:title>The quality of reporting of randomised controlled trials in asthma: systematic review protocol.</gtr:title><gtr:parentPublicationTitle>Primary care respiratory journal : journal of the General Practice Airways Group</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f3cd90b7ec0d1aabf605c09af72a44ff"><gtr:id>f3cd90b7ec0d1aabf605c09af72a44ff</gtr:id><gtr:otherNames>Ntala C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1471-4418</gtr:issn><gtr:outcomeId>doi_12896_2013_00003</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A4D5626-F94C-4E08-A2C2-B584CC595491</gtr:id><gtr:title>The authors say: 'The data are not so robust because of heterogeneity' - so, how should I deal with this systematic review? Meta-analysis and the clinician.</gtr:title><gtr:parentPublicationTitle>Cerebrovascular diseases (Basel, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dd709aad3f5a6eca29e8d074bee23e6a"><gtr:id>dd709aad3f5a6eca29e8d074bee23e6a</gtr:id><gtr:otherNames>Sandercock P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1015-9770</gtr:issn><gtr:outcomeId>pm_12896_26_21494032</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DD5412C1-F9C5-4EC6-A7C9-EAB652B64732</gtr:id><gtr:title>Bronchial nitric oxide flux (J'aw) is sensitive to oral corticosteroids in smokers with asthma.</gtr:title><gtr:parentPublicationTitle>Respiratory medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ab6f534d70f0342b3db041d664df9e60"><gtr:id>ab6f534d70f0342b3db041d664df9e60</gtr:id><gtr:otherNames>Spears M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0954-6111</gtr:issn><gtr:outcomeId>hoybTuCuc2H</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E6BD4ACD-9EAA-490F-BF7A-6D610E44A826</gtr:id><gtr:title>IMPACT recommendations for improving the design and analysis of clinical trials in moderate to severe traumatic brain injury.</gtr:title><gtr:parentPublicationTitle>Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0ec4e42e1fc0357ce8491d3f45519d64"><gtr:id>0ec4e42e1fc0357ce8491d3f45519d64</gtr:id><gtr:otherNames>Maas AI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1878-7479</gtr:issn><gtr:outcomeId>owQLmdKx8xu</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ABF1F50B-0D5D-4565-B4D8-37123A716411</gtr:id><gtr:title>A tool to assess the quality of a meta-analysis.</gtr:title><gtr:parentPublicationTitle>Research synthesis methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/62f63221dc061f0b790a217a27e32074"><gtr:id>62f63221dc061f0b790a217a27e32074</gtr:id><gtr:otherNames>Higgins JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1759-2879</gtr:issn><gtr:outcomeId>doi_12896__jrsm_1092</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>35180CF7-9835-44D9-A0A6-E77CB6124C10</gtr:id><gtr:title>Nitrous oxide exposure does not seem to be associated with increased mortality, stroke, and myocardial infarction: a non-randomized subgroup analysis of the General Anaesthesia compared with Local Anaesthesia for carotid surgery (GALA) trial.</gtr:title><gtr:parentPublicationTitle>British journal of anaesthesia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f2e5b1ee3098b90568bcaf68ba8fb2f9"><gtr:id>f2e5b1ee3098b90568bcaf68ba8fb2f9</gtr:id><gtr:otherNames>Sanders RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0007-0912</gtr:issn><gtr:outcomeId>pm_12896_26_22710267</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1A09FD1B-230E-4342-8092-2B13047925BE</gtr:id><gtr:title>Update on the Surgical Trial in Lobar Intracerebral Haemorrhage (STICH II): statistical analysis plan.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e8ed06028f2d341ac6866a363f28f99"><gtr:id>8e8ed06028f2d341ac6866a363f28f99</gtr:id><gtr:otherNames>Gregson BA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>pm_12896_26_23171588</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D66E7990-E9C3-49E0-A306-0513EDA586CF</gtr:id><gtr:title>Untreated clinical course of cerebral cavernous malformations: a prospective, population-based cohort study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/465202a0e76a70c877a9acff11c95c35"><gtr:id>465202a0e76a70c877a9acff11c95c35</gtr:id><gtr:otherNames>Al-Shahi Salman R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>pm_12896_26_22297119</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>51FE7E1C-369E-4DB4-9BCF-3706DB0742A3</gtr:id><gtr:title>Simvastatin in aneurysmal subarachnoid haemorrhage (STASH): a multicentre randomised phase 3 trial.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6352e60b6db77c6643b71a7fd04cdd00"><gtr:id>6352e60b6db77c6643b71a7fd04cdd00</gtr:id><gtr:otherNames>Kirkpatrick PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>54524fe1f0b1c2.19871112</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0A00EB88-FA67-48D3-9B07-F7676B31CAD9</gtr:id><gtr:title>Blood rheology and cognition in the Edinburgh Type 2 Diabetes Study.</gtr:title><gtr:parentPublicationTitle>Age and ageing</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/92c807dd74c086f13d2174d70fc9bf1c"><gtr:id>92c807dd74c086f13d2174d70fc9bf1c</gtr:id><gtr:otherNames>Marioni RE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0002-0729</gtr:issn><gtr:outcomeId>Vau6o92nihR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EE5E5FDE-186A-4C84-950E-AF134625386E</gtr:id><gtr:title>Publication bias in reports of animal stroke studies leads to major overstatement of efficacy.</gtr:title><gtr:parentPublicationTitle>PLoS biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/45ee6dcb5589cc6e38b589141c81d037"><gtr:id>45ee6dcb5589cc6e38b589141c81d037</gtr:id><gtr:otherNames>Sena ES</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1544-9173</gtr:issn><gtr:outcomeId>CtXt3xZUnh9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A95A348-6DA0-43FA-810D-FC981B28D7C4</gtr:id><gtr:title>Effect of a lifestyle intervention on weight change in south Asian individuals in the UK at high risk of type 2 diabetes: a family-cluster randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>The lancet. Diabetes &amp; endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/506b9331177801ea5ae83c01e3ce608f"><gtr:id>506b9331177801ea5ae83c01e3ce608f</gtr:id><gtr:otherNames>Bhopal RS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2213-8587</gtr:issn><gtr:outcomeId>54524fe17bef09.24964200</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C68ED34D-19F8-44FB-9A1D-30B5924B85E3</gtr:id><gtr:title>A meta-analysis of genome-wide association studies identifies novel variants associated with osteoarthritis of the hip.</gtr:title><gtr:parentPublicationTitle>Annals of the rheumatic diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f41551d5aab7d7e9f0f6b8d91ef697d9"><gtr:id>f41551d5aab7d7e9f0f6b8d91ef697d9</gtr:id><gtr:otherNames>Evangelou E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0003-4967</gtr:issn><gtr:outcomeId>doi_12896_012_203114</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF860C9F-509B-4727-8741-4BAC778F7EF8</gtr:id><gtr:title>Formal and informal prediction of recurrent stroke and myocardial infarction after stroke: a systematic review and evaluation of clinical prediction models in a new cohort.</gtr:title><gtr:parentPublicationTitle>BMC medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d21a9944b6062ae4454025970fd10809"><gtr:id>d21a9944b6062ae4454025970fd10809</gtr:id><gtr:otherNames>Thompson DD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1741-7015</gtr:issn><gtr:outcomeId>543e9446992888.97310219</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>028614EF-FEDE-4857-835A-7E517ED8950C</gtr:id><gtr:title>Clinical course of untreated cerebral cavernous malformations: a meta-analysis of individual patient data.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/db42d1cfaf0a5fe581d96d1e71804ae3"><gtr:id>db42d1cfaf0a5fe581d96d1e71804ae3</gtr:id><gtr:otherNames>Horne MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>56af3d401fafc0.07537888</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>372DF35A-2D1D-4362-AB98-0AE038C49AD8</gtr:id><gtr:title>Efficacy of metformin in pregnant obese women: a randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7490c73a69340d28c6adb50a04f35bb8"><gtr:id>7490c73a69340d28c6adb50a04f35bb8</gtr:id><gtr:otherNames>Chiswick CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>56af3f00633bd4.06735787</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9F555BC6-714B-4239-8C68-6D89FEDDBD8F</gtr:id><gtr:title>Thigh-length versus below-knee stockings for deep venous thrombosis prophylaxis after stroke: a randomized trial.</gtr:title><gtr:parentPublicationTitle>Annals of internal medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/00a66fe3d6558f5267028588434cc832"><gtr:id>00a66fe3d6558f5267028588434cc832</gtr:id><gtr:otherNames>CLOTS (Clots in Legs Or sTockings after Stroke) Trial Collaboration</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0003-4819</gtr:issn><gtr:outcomeId>kSKcqTn6rsd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>61646E99-3C91-46C0-8B52-B07B4CE53818</gtr:id><gtr:title>The influence of enrollment criteria on recruitment and outcome distribution in traumatic brain injury studies: results from the impact study.</gtr:title><gtr:parentPublicationTitle>Journal of neurotrauma</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/58817ae986e78252e679b5980b439ab3"><gtr:id>58817ae986e78252e679b5980b439ab3</gtr:id><gtr:otherNames>Roozenbeek B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0897-7151</gtr:issn><gtr:outcomeId>29E1CFEDF27</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D6776600-2E72-40C8-892A-81B3DF4F6FF2</gtr:id><gtr:title>How many patients might receive thrombolytic therapy in the light of the ECASS-3 and IST-3 data?</gtr:title><gtr:parentPublicationTitle>International journal of stroke : official journal of the International Stroke Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/66decab834dd1b016049f8488474aa28"><gtr:id>66decab834dd1b016049f8488474aa28</gtr:id><gtr:otherNames>Bembenek J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1747-4930</gtr:issn><gtr:outcomeId>EWG9nKneEuD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>72E8349F-93C5-4344-A2FE-1CD9C38B37BC</gtr:id><gtr:title>Preclinical drug evaluation for combination therapy in acute stroke using systematic review, meta-analysis, and subsequent experimental testing.</gtr:title><gtr:parentPublicationTitle>Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2683f793ae32e332af64202093f13fe0"><gtr:id>2683f793ae32e332af64202093f13fe0</gtr:id><gtr:otherNames>O'Collins VE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0271-678X</gtr:issn><gtr:outcomeId>tDYi598R53T</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F376BC3E-B585-45F3-BCEF-6B531E10290E</gtr:id><gtr:title>Sitting time and waist circumference are associated with glycemia in U.K. South Asians: data from 1,228 adults screened for the PODOSA trial.</gtr:title><gtr:parentPublicationTitle>Diabetes care</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/114d222f3c1c486224d5bcc8367608c3"><gtr:id>114d222f3c1c486224d5bcc8367608c3</gtr:id><gtr:otherNames>Gill JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0149-5992</gtr:issn><gtr:outcomeId>Tb2ke6ZUJ6W</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F1B44E0D-8D19-4C25-8EBF-0CCB801E2F74</gtr:id><gtr:title>Clinical scores for the identification of stroke and transient ischaemic attack in the emergency department: a cross-sectional study.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f67a36f4c44c4922a18eaf376974507b"><gtr:id>f67a36f4c44c4922a18eaf376974507b</gtr:id><gtr:otherNames>Whiteley WN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>pm_12896_26_21402744</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>576BDC5B-E026-4D43-B4E7-3E588CBFB66C</gtr:id><gtr:title>Surviving intensive care: a systematic review of healthcare resource use after hospital discharge*.</gtr:title><gtr:parentPublicationTitle>Critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dfb032ea0c3f6c42b22b55ad8dfc324e"><gtr:id>dfb032ea0c3f6c42b22b55ad8dfc324e</gtr:id><gtr:otherNames>Lone NI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0090-3493</gtr:issn><gtr:outcomeId>pm_12896_26_23782967</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C1F096A-D8D5-4294-A7C7-9D3FA1A9097E</gtr:id><gtr:title>The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/12c7afbed82d8caa4bccf507dbc328ea"><gtr:id>12c7afbed82d8caa4bccf507dbc328ea</gtr:id><gtr:otherNames>IST-3 collaborative group</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>pm_12896_26_22632908</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AD76A8DD-3B31-4A90-9802-D89E6196AE1F</gtr:id><gtr:title>Patient and general practitioner preferences for the treatment of depression in patients with cancer: how, who, and where?</gtr:title><gtr:parentPublicationTitle>Journal of psychosomatic research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b979aa112505ed58ac63cd1c05c27d20"><gtr:id>b979aa112505ed58ac63cd1c05c27d20</gtr:id><gtr:otherNames>Hodges L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-3999</gtr:issn><gtr:outcomeId>3560E68178C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>54C60862-DC34-4337-919B-56FB8F31C139</gtr:id><gtr:title>Which neurological diseases are most likely to be associated with &amp;quot;symptoms unexplained by organic disease&amp;quot;.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89df86805aa041d4da8d635bbf45d7ca"><gtr:id>89df86805aa041d4da8d635bbf45d7ca</gtr:id><gtr:otherNames>Stone J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>ASEmurqutGA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A4CCFB14-59ED-4319-9095-DBDEF38609C9</gtr:id><gtr:title>The Clots in Legs Or sTockings after Stroke (CLOTS) 3 trial: a randomised controlled trial to determine whether or not intermittent pneumatic compression reduces the risk of post-stroke deep vein thrombosis and to estimate its cost-effectiveness.</gtr:title><gtr:parentPublicationTitle>Health technology assessment (Winchester, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8a64354cef682d91105e2c9e80246794"><gtr:id>8a64354cef682d91105e2c9e80246794</gtr:id><gtr:otherNames>Dennis M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1366-5278</gtr:issn><gtr:outcomeId>56af3efdbfbc39.29622006</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>69512104-A31F-4E16-864A-F2C40FCC5D8C</gtr:id><gtr:title>Protocol for a systematic review and individual patient data meta-analysis of prognostic factors of foot ulceration in people with diabetes: the international research collaboration for the prediction of diabetic foot ulcerations (PODUS).</gtr:title><gtr:parentPublicationTitle>BMC medical research methodology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7caf08ea521ae8777e689866dc68cf39"><gtr:id>7caf08ea521ae8777e689866dc68cf39</gtr:id><gtr:otherNames>Crawford F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1471-2288</gtr:issn><gtr:outcomeId>pm_12896_26_23414550</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B606986E-B2D7-49CC-9050-2A94F4DE0C4B</gtr:id><gtr:title>UK publicly funded Clinical Trials Units supported a controlled access approach to share individual participant data but highlighted concerns.</gtr:title><gtr:parentPublicationTitle>Journal of clinical epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/50c53ac5efc52c6e7ca263d0bf9ed86a"><gtr:id>50c53ac5efc52c6e7ca263d0bf9ed86a</gtr:id><gtr:otherNames>Hopkins C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0895-4356</gtr:issn><gtr:outcomeId>56af3c966199f2.31014615</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>03C8D0F6-D626-4B29-AB98-D3218E7FB49B</gtr:id><gtr:title>Increased Hospital-Based Physical Rehabilitation and Information Provision After Intensive Care Unit Discharge: The RECOVER Randomized Clinical Trial.</gtr:title><gtr:parentPublicationTitle>JAMA internal medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f9b90c3bc89a25541abb71483af4e188"><gtr:id>f9b90c3bc89a25541abb71483af4e188</gtr:id><gtr:otherNames>Walsh TS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2168-6106</gtr:issn><gtr:outcomeId>56af3eff781214.64211682</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C49AB9E7-0545-44B7-95DF-B6A13047EEC3</gtr:id><gtr:title>Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): a multicentre, randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5c3c4bd2094140856037ffd7dca8c05a"><gtr:id>5c3c4bd2094140856037ffd7dca8c05a</gtr:id><gtr:otherNames>CLOTS Trials Collaboration</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>9407FD689FF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4BCA6051-B045-4A3C-B7B4-C80A49C9C28F</gtr:id><gtr:title>Application of Variable Life Adjusted Display (VLAD) to risk-adjusted mortality of esophagogastric cancer surgery.</gtr:title><gtr:parentPublicationTitle>World journal of surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dacfaf75c7db7dc118bf4029c2544a3e"><gtr:id>dacfaf75c7db7dc118bf4029c2544a3e</gtr:id><gtr:otherNames>Guest RV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0364-2313</gtr:issn><gtr:outcomeId>pm_12896_26_21964818</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2285721E-5F44-48FA-8DDF-C0D1F66325C4</gtr:id><gtr:title>Statistical analysis plan for the third International Stroke Trial (IST-3); part of a 'thread' of reports of the trial.</gtr:title><gtr:parentPublicationTitle>International journal of stroke : official journal of the International Stroke Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dd709aad3f5a6eca29e8d074bee23e6a"><gtr:id>dd709aad3f5a6eca29e8d074bee23e6a</gtr:id><gtr:otherNames>Sandercock P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1747-4930</gtr:issn><gtr:outcomeId>pm_12896_26_22405276</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9BCA4854-B4B9-493D-8C12-33D5B42C0370</gtr:id><gtr:title>Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial.</gtr:title><gtr:parentPublicationTitle>The Lancet. Respiratory medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1c88971207b07f5944c6a06035fff72"><gtr:id>e1c88971207b07f5944c6a06035fff72</gtr:id><gtr:otherNames>Alton EWFW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2213-2600</gtr:issn><gtr:outcomeId>56af3efef0f542.57947929</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA75E597-7CF6-4351-B713-5E1242002BE6</gtr:id><gtr:title>Restrictive versus liberal transfusion strategies for older mechanically ventilated critically ill patients: a randomized pilot trial.</gtr:title><gtr:parentPublicationTitle>Critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f9b90c3bc89a25541abb71483af4e188"><gtr:id>f9b90c3bc89a25541abb71483af4e188</gtr:id><gtr:otherNames>Walsh TS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0090-3493</gtr:issn><gtr:outcomeId>pm_12896_26_23939351</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7180EE6B-BBA9-4FF6-A863-9FEEF78742E5</gtr:id><gtr:title>Does the extended Glasgow Outcome Scale add value to the conventional Glasgow Outcome Scale?</gtr:title><gtr:parentPublicationTitle>Journal of neurotrauma</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bdda10608e0c19b7aab31cf7d0c0195a"><gtr:id>bdda10608e0c19b7aab31cf7d0c0195a</gtr:id><gtr:otherNames>Weir J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0897-7151</gtr:issn><gtr:outcomeId>pm_12896_26_22026476</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB8EE2E9-E3FF-4374-9A63-7223C825315F</gtr:id><gtr:title>Baseline characteristics and statistical power in randomized controlled trials: selection, prognostic targeting, or covariate adjustment?</gtr:title><gtr:parentPublicationTitle>Critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/58817ae986e78252e679b5980b439ab3"><gtr:id>58817ae986e78252e679b5980b439ab3</gtr:id><gtr:otherNames>Roozenbeek B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0090-3493</gtr:issn><gtr:outcomeId>AED3D419B86</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>325F4CE1-7ABB-41CE-9B60-B1CA14361F4C</gtr:id><gtr:title>Automated data capture from free-text radiology reports to enhance accuracy of hospital inpatient stroke codes.</gtr:title><gtr:parentPublicationTitle>Pharmacoepidemiology and drug safety</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93069e26b264fca1219177db5f102541"><gtr:id>93069e26b264fca1219177db5f102541</gtr:id><gtr:otherNames>Flynn RW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1053-8569</gtr:issn><gtr:outcomeId>G7pD4wikWvx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DD0CB2E1-D881-4E83-A445-98B1A200D2B7</gtr:id><gtr:title>Intelligence and persisting with medication for two years: Analysis in a randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>Intelligence</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/775e244868628ab285a4d75d93fbf7c6"><gtr:id>775e244868628ab285a4d75d93fbf7c6</gtr:id><gtr:otherNames>Deary IJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0160-2896</gtr:issn><gtr:outcomeId>13216E7D22B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BCED0FE4-B5DA-41AE-8503-247152FCCEC2</gtr:id><gtr:title>Design and baseline characteristics of the PODOSA (Prevention of Diabetes &amp;amp; Obesity in South Asians) trial: a cluster, randomised lifestyle intervention in Indian and Pakistani adults with impaired glycaemia at high risk of developing type 2 diabetes.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/438e355888c23bc2cef769105af3c36f"><gtr:id>438e355888c23bc2cef769105af3c36f</gtr:id><gtr:otherNames>Douglas A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>543e944575e4f9.35752307</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6B2257D-D537-45A1-ABA0-E64277EE5151</gtr:id><gtr:title>Death after head injury: the 13 year outcome of a case control study.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/862d8aede687d64190f0790f3e4e3b05"><gtr:id>862d8aede687d64190f0790f3e4e3b05</gtr:id><gtr:otherNames>McMillan TM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>H6V4Hopda5d</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>497DC559-1EDB-4F9E-BAEA-89EAD2A0F26D</gtr:id><gtr:title>Who is referred to neurology clinics?--the diagnoses made in 3781 new patients.</gtr:title><gtr:parentPublicationTitle>Clinical neurology and neurosurgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89df86805aa041d4da8d635bbf45d7ca"><gtr:id>89df86805aa041d4da8d635bbf45d7ca</gtr:id><gtr:otherNames>Stone J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0303-8467</gtr:issn><gtr:outcomeId>YZ9oGoMXQE9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C9413FA5-59F8-47ED-82FC-757178E867A0</gtr:id><gtr:title>Angiotensin receptor blockade in acute stroke. The Scandinavian Candesartan Acute Stroke Trial: rationale, methods and design of a multicentre, randomised- and placebo-controlled clinical trial (NCT00120003).</gtr:title><gtr:parentPublicationTitle>International journal of stroke : official journal of the International Stroke Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d5ee0623edd53b569cccc8391410d84"><gtr:id>9d5ee0623edd53b569cccc8391410d84</gtr:id><gtr:otherNames>Sandset EC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1747-4930</gtr:issn><gtr:outcomeId>TeKr3AdDTGN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1D50B61B-A25F-4C7A-AEC5-4DD05FB3B4B2</gtr:id><gtr:title>Non-pharmacological interventions for caregivers of stroke survivors.</gtr:title><gtr:parentPublicationTitle>The Cochrane database of systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b7a8610a1b8611357056ded0a4f00f4c"><gtr:id>b7a8610a1b8611357056ded0a4f00f4c</gtr:id><gtr:otherNames>Legg LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1361-6137</gtr:issn><gtr:outcomeId>pm_12896_26_21975778</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B2312596-AA93-404B-B238-75D3FFE390AE</gtr:id><gtr:title>Exploring the role and function of trial steering committees: results of an expert panel meeting.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/563710b15a31a4a26184221dac7791dd"><gtr:id>563710b15a31a4a26184221dac7791dd</gtr:id><gtr:otherNames>Harman NL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>56af3d410ea3c1.13976178</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2CD74ED2-8369-4136-AA1D-828A79E0C5F4</gtr:id><gtr:title>Methodology of a large prospective, randomised, open, blinded endpoint streamlined safety study of celecoxib versus traditional non-steroidal anti-inflammatory drugs in patients with osteoarthritis or rheumatoid arthritis: protocol of the standard care versus celecoxib outcome trial (SCOT).</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b06fcf295cf74e8a623e0c973c8664fb"><gtr:id>b06fcf295cf74e8a623e0c973c8664fb</gtr:id><gtr:otherNames>Macdonald TM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>543e9445a77977.86252212</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>859EDCF6-295A-4E8C-AB21-45DCE80ECC30</gtr:id><gtr:title>Somatic symptom count scores do not identify patients with symptoms unexplained by disease: a prospective cohort study of neurology outpatients.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25203d5ae73915c7de4e489e605f505b"><gtr:id>25203d5ae73915c7de4e489e605f505b</gtr:id><gtr:otherNames>Carson AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>54524fe1a4f5f9.85894445</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A396055E-10D9-43DD-8D0C-80D0D516E2C4</gtr:id><gtr:title>Investigating the effectiveness of the Mediterranean diet in pregnant women for the primary prevention of asthma and allergy in high-risk infants: protocol for a pilot randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5444a756b8f6f046936bb8797e5348ce"><gtr:id>5444a756b8f6f046936bb8797e5348ce</gtr:id><gtr:otherNames>Sewell DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>543e94470550a5.44497597</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>051EDA6A-FE0D-4CAB-A9ED-5F0FDBABC667</gtr:id><gtr:title>Association of KIBRA and memory.</gtr:title><gtr:parentPublicationTitle>Neuroscience letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5353387564f2f3def865f4986b8660cd"><gtr:id>5353387564f2f3def865f4986b8660cd</gtr:id><gtr:otherNames>Bates TC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0304-3940</gtr:issn><gtr:outcomeId>A13C4A3072E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E911F196-4396-417A-8382-6E575C04B9EE</gtr:id><gtr:title>Treatment of depression in adults with cancer: a systematic review of randomized controlled trials.</gtr:title><gtr:parentPublicationTitle>Psychological medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a3aabcaa9fd883d77d7401fb9ae5630"><gtr:id>5a3aabcaa9fd883d77d7401fb9ae5630</gtr:id><gtr:otherNames>Walker J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0033-2917</gtr:issn><gtr:outcomeId>doi_12896_1713001372</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6DEE884-19E5-4C61-A353-E4EE107F7002</gtr:id><gtr:title>Disability, distress and unemployment in neurology outpatients with symptoms 'unexplained by organic disease'.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ded25e1fb8764740f665b9af2f17b082"><gtr:id>ded25e1fb8764740f665b9af2f17b082</gtr:id><gtr:otherNames>Carson A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>Zjp45evCwD6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F534A562-44B3-43F6-ABAB-F685088079F5</gtr:id><gtr:title>The Tayside Stroke Cohort: exploiting advanced regional medical informatics to create a region-wide database for studying the pharmacoepidemiology of stroke.</gtr:title><gtr:parentPublicationTitle>Pharmacoepidemiology and drug safety</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93069e26b264fca1219177db5f102541"><gtr:id>93069e26b264fca1219177db5f102541</gtr:id><gtr:otherNames>Flynn RW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1053-8569</gtr:issn><gtr:outcomeId>psDdEqrJax4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B83A4CD-19D0-4B7E-94CA-3FDFDBF10738</gtr:id><gtr:title>Prescribing antiplatelet medicine and subsequent events after intracerebral hemorrhage.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93069e26b264fca1219177db5f102541"><gtr:id>93069e26b264fca1219177db5f102541</gtr:id><gtr:otherNames>Flynn RW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn><gtr:outcomeId>q2L3dcLF63S</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63A04EB2-D6F2-47DF-965C-AE734A36F698</gtr:id><gtr:title>Screening for major depression in cancer outpatients: the diagnostic accuracy of the 9-item patient health questionnaire.</gtr:title><gtr:parentPublicationTitle>Cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dc25e1d46b5e3d67350369e3c1064ea7"><gtr:id>dc25e1d46b5e3d67350369e3c1064ea7</gtr:id><gtr:otherNames>Thekkumpurath P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0008-543X</gtr:issn><gtr:outcomeId>HE56DRuHa2S</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F3120E4D-E5DB-4404-9D02-91B85FB445B6</gtr:id><gtr:title>Targeted rehabilitation to improve outcome after total knee replacement (TRIO): study protocol for a randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/093c3fbf2fa5ccf8a2e705fd026c42c3"><gtr:id>093c3fbf2fa5ccf8a2e705fd026c42c3</gtr:id><gtr:otherNames>Simpson AH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>545250ee88a344.62275308</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FD07BFB8-D634-494B-B25B-5F25B617CB80</gtr:id><gtr:title>Methodological quality of meta-analyses: matched-pairs comparison over time and between industry-sponsored and academic-sponsored reports.</gtr:title><gtr:parentPublicationTitle>Research synthesis methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8fe7d0f2f3b8939f8065331b1f9b1bed"><gtr:id>8fe7d0f2f3b8939f8065331b1f9b1bed</gtr:id><gtr:otherNames>Lane PW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1759-2879</gtr:issn><gtr:outcomeId>doi_12896__jrsm_1072</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A68F4B7-489A-4B65-84A7-2BCC50B19420</gtr:id><gtr:title>Cost-effectiveness of integrated collaborative care for comorbid major depression in patients with cancer.</gtr:title><gtr:parentPublicationTitle>Journal of psychosomatic research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eb18e986ce119ba193debf8f657cc518"><gtr:id>eb18e986ce119ba193debf8f657cc518</gtr:id><gtr:otherNames>Duarte A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-3999</gtr:issn><gtr:outcomeId>56af3d3fd58756.29737349</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>86435FB2-5386-4BE2-9F5E-14714B62036C</gtr:id><gtr:title>Persistence, adherence and outcomes with antiplatelet regimens following cerebral infarction in the Tayside Stroke Cohort.</gtr:title><gtr:parentPublicationTitle>Cerebrovascular diseases (Basel, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93069e26b264fca1219177db5f102541"><gtr:id>93069e26b264fca1219177db5f102541</gtr:id><gtr:otherNames>Flynn RW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1015-9770</gtr:issn><gtr:outcomeId>pm_12896_26_22261482</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2820FE4F-E63A-449F-BBF2-83EED7EB4810</gtr:id><gtr:title>The effect of graduated compression stockings on long-term outcomes after stroke: the CLOTS trials 1 and 2.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5c3c4bd2094140856037ffd7dca8c05a"><gtr:id>5c3c4bd2094140856037ffd7dca8c05a</gtr:id><gtr:otherNames>CLOTS Trials Collaboration</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn><gtr:outcomeId>pm_12896_26_23482600</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>82298C41-F81C-4467-9136-00B43752D96F</gtr:id><gtr:title>Acceptability and perceived barriers and facilitators to creating a national research register to enable 'direct to patient' enrolment into research: the Scottish Health Research Register (SHARE).</gtr:title><gtr:parentPublicationTitle>BMC health services research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3dffec1eae0084b9104755ca59bb5dce"><gtr:id>3dffec1eae0084b9104755ca59bb5dce</gtr:id><gtr:otherNames>Grant A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1472-6963</gtr:issn><gtr:outcomeId>543e944668adb8.84163041</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>50B24D03-E55A-4D55-A77B-684D9AD4EDA5</gtr:id><gtr:title>Covariate adjustment had similar benefits in small and large randomized controlled trials.</gtr:title><gtr:parentPublicationTitle>Journal of clinical epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d21a9944b6062ae4454025970fd10809"><gtr:id>d21a9944b6062ae4454025970fd10809</gtr:id><gtr:otherNames>Thompson DD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0895-4356</gtr:issn><gtr:outcomeId>5675dda6beaf9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>454F43F4-1B28-4F5D-A956-85DB5FBD2B45</gtr:id><gtr:title>The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d5ee0623edd53b569cccc8391410d84"><gtr:id>9d5ee0623edd53b569cccc8391410d84</gtr:id><gtr:otherNames>Sandset EC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>i7qZeAJMyNY</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6D917D20-B65F-4331-9FAB-89A692750F8A</gtr:id><gtr:title>The impact of supported telemetric monitoring in people with type 2 diabetes: study protocol for a randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa108a4b83c119fee9e80c7a1d9bc2c5"><gtr:id>fa108a4b83c119fee9e80c7a1d9bc2c5</gtr:id><gtr:otherNames>Wild S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>543e94473ec174.93156616</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A61E129-0C5C-49E5-AFA3-2E22FD2D887D</gtr:id><gtr:title>The International Stroke Trial database.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ea38e02da3e7bdf2e59459b2ad04c2f2"><gtr:id>ea38e02da3e7bdf2e59459b2ad04c2f2</gtr:id><gtr:otherNames>Sandercock PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>pm_12896_26_21510853</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2C71E92-1AD1-474F-8D84-9D7E7D0752BD</gtr:id><gtr:title>Cytokine gene polymorphisms and outcome after traumatic brain injury.</gtr:title><gtr:parentPublicationTitle>Journal of neurotrauma</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f38c5adb533a2f86d4e96b9d3fd41b5"><gtr:id>5f38c5adb533a2f86d4e96b9d3fd41b5</gtr:id><gtr:otherNames>Waters RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0897-7151</gtr:issn><gtr:outcomeId>543e94447f4607.91685554</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D4973F6-5E91-4765-A4F3-E8D696EE35E4</gtr:id><gtr:title>Factors affecting the apparent efficacy and safety of tissue plasminogen activator in thrombotic occlusion models of stroke: systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/45ee6dcb5589cc6e38b589141c81d037"><gtr:id>45ee6dcb5589cc6e38b589141c81d037</gtr:id><gtr:otherNames>Sena ES</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0271-678X</gtr:issn><gtr:outcomeId>q54bE1nmbbc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8434C6D6-D45E-49B3-B9E0-2524FAC7F7E1</gtr:id><gtr:title>Characterization of cancer-induced bone pain: an exploratory study.</gtr:title><gtr:parentPublicationTitle>Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9a2fd8e1979cef419f7d26aa5f2109fd"><gtr:id>9a2fd8e1979cef419f7d26aa5f2109fd</gtr:id><gtr:otherNames>Laird BJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0941-4355</gtr:issn><gtr:outcomeId>CX4CashSPbb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38EB1940-4173-44F7-B69B-93BB8A3827F1</gtr:id><gtr:title>Planning trials in older patients with stroke: data from the International Stroke Trial.</gtr:title><gtr:parentPublicationTitle>Age and ageing</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/469223f6980e6eef63a23811e9568ce3"><gtr:id>469223f6980e6eef63a23811e9568ce3</gtr:id><gtr:otherNames>Niewada M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0002-0729</gtr:issn><gtr:outcomeId>pm_12896_26_21447486</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE5646FC-CA84-407E-A874-61058089E63D</gtr:id><gtr:title>Rationale, design, and baseline characteristics of the Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease (SIGNIFY trial): a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease without clinical heart failure.</gtr:title><gtr:parentPublicationTitle>American heart journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/729f24b3670b863ab7f2a80301175bc3"><gtr:id>729f24b3670b863ab7f2a80301175bc3</gtr:id><gtr:otherNames>Fox K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0002-8703</gtr:issn><gtr:outcomeId>doi_12896_013_06_024</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>62BB9242-7E52-466A-9D21-041ADECE5AE7</gtr:id><gtr:title>Surgical trial in lobar intracerebral haemorrhage (STICH II) protocol.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aebe6039cfa9ba1edd91fdcf3c128eb4"><gtr:id>aebe6039cfa9ba1edd91fdcf3c128eb4</gtr:id><gtr:otherNames>Mendelow AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>ms98MbNWxfM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4019CF3B-0470-4DD0-8577-4AFA70BA6E8B</gtr:id><gtr:title>Effect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR): a randomised, double-blind, placebo-controlled trial.</gtr:title><gtr:parentPublicationTitle>The lancet. Diabetes &amp; endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d56c77feaac3469d37bc80a2513e04d"><gtr:id>2d56c77feaac3469d37bc80a2513e04d</gtr:id><gtr:otherNames>Chiswick C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2213-8587</gtr:issn><gtr:outcomeId>56af3efe90a971.57680224</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DE4BC035-9939-430E-B8D3-EEAD1B82C2F8</gtr:id><gtr:title>Cancer pain and its relationship to systemic inflammation: an exploratory study.</gtr:title><gtr:parentPublicationTitle>Pain</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9a2fd8e1979cef419f7d26aa5f2109fd"><gtr:id>9a2fd8e1979cef419f7d26aa5f2109fd</gtr:id><gtr:otherNames>Laird BJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0304-3959</gtr:issn><gtr:outcomeId>pm_12896_26_21159432</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E17AE6D-F5F4-490B-8B64-F9EE8C7162BB</gtr:id><gtr:title>Advancing care for traumatic brain injury: findings from the IMPACT studies and perspectives on future research.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0ec4e42e1fc0357ce8491d3f45519d64"><gtr:id>0ec4e42e1fc0357ce8491d3f45519d64</gtr:id><gtr:otherNames>Maas AI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>543e9444222af4.05947348</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>45891F9F-5086-40CE-BB2E-3E4A9A4543B3</gtr:id><gtr:title>Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dd709aad3f5a6eca29e8d074bee23e6a"><gtr:id>dd709aad3f5a6eca29e8d074bee23e6a</gtr:id><gtr:otherNames>Sandercock P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>pm_12896_26_22129158</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B0F33D7-6BB1-4757-B9CC-8C3949287843</gtr:id><gtr:title>Group therapy for people with bulimia nervosa: systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>Psychological medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0330074bb698183de17c54daf1fda9b2"><gtr:id>0330074bb698183de17c54daf1fda9b2</gtr:id><gtr:otherNames>Polnay A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0033-2917</gtr:issn><gtr:outcomeId>54524fe24e72b6.63958976</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>67988A67-83AA-4405-ABC1-FDBF4F5A2B0E</gtr:id><gtr:title>Fatigue after stroke: baseline predictors and influence on survival. Analysis of data from UK patients recruited in the International Stroke Trial.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d2f6ddcd0cf4e567be80b6187d180c9f"><gtr:id>d2f6ddcd0cf4e567be80b6187d180c9f</gtr:id><gtr:otherNames>Mead GE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>guzD39GhQiG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB3A2C69-D165-4E49-81B9-3EB21E5639C3</gtr:id><gtr:title>Negative results: why do they need to be published?</gtr:title><gtr:parentPublicationTitle>International journal of stroke : official journal of the International Stroke Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dd709aad3f5a6eca29e8d074bee23e6a"><gtr:id>dd709aad3f5a6eca29e8d074bee23e6a</gtr:id><gtr:otherNames>Sandercock P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1747-4930</gtr:issn><gtr:outcomeId>pm_12896_26_22188851</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8BDECCA3-2E1A-455C-A5D4-5597BC82EA36</gtr:id><gtr:title>Outcome after surgical or conservative management of cerebral cavernous malformations.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5c1dbb5b22be0db92a6593a4bc58d4bb"><gtr:id>5c1dbb5b22be0db92a6593a4bc58d4bb</gtr:id><gtr:otherNames>Moultrie F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>543e9448325d78.21371749</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>10E15E4F-55E6-4C59-80D2-FA01663B8EDF</gtr:id><gtr:title>Scottish and Newcastle antiemetic pre-treatment for paracetamol poisoning study (SNAP).</gtr:title><gtr:parentPublicationTitle>BMC pharmacology &amp; toxicology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/98bd8638e0f0f0cadc30dbc489a72fce"><gtr:id>98bd8638e0f0f0cadc30dbc489a72fce</gtr:id><gtr:otherNames>Thanacoody HK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2050-6511</gtr:issn><gtr:outcomeId>543e9448024f33.44341050</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA2AC918-30EC-469C-80BC-F9E92A57375E</gtr:id><gtr:title>Response to letter regarding article, &amp;quot;Targeting recombinant tissue-type plasminogen activator in acute ischemic stroke based on risk of intracranial hemorrhage or poor functional outcome: an analysis of the Third International Stroke Trial&amp;quot;.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f67a36f4c44c4922a18eaf376974507b"><gtr:id>f67a36f4c44c4922a18eaf376974507b</gtr:id><gtr:otherNames>Whiteley WN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn><gtr:outcomeId>pm_540e15fe15fb40a06</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>44A8B051-B864-4F64-B765-26411CA03C5A</gtr:id><gtr:title>Factors associated with outcome and duration of therapy in outpatient parenteral antibiotic therapy (OPAT) patients with skin and soft-tissue infections.</gtr:title><gtr:parentPublicationTitle>International journal of antimicrobial agents</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f5e182b707ebf19257d1ce4a10f7e011"><gtr:id>f5e182b707ebf19257d1ce4a10f7e011</gtr:id><gtr:otherNames>Seaton RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0924-8579</gtr:issn><gtr:outcomeId>pPce33BoYrb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>806E1F43-6CDB-4695-9C6D-C354A7E05071</gtr:id><gtr:title>How should individual participant data (IPD) from publicly funded clinical trials be shared?</gtr:title><gtr:parentPublicationTitle>BMC medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63e74e8623ca55eface3c41e51bceb20"><gtr:id>63e74e8623ca55eface3c41e51bceb20</gtr:id><gtr:otherNames>Tudur Smith C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1741-7015</gtr:issn><gtr:outcomeId>56af3d41407897.42975757</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>021F046A-CEC4-4F58-AF1A-A0DB5E9EEF62</gtr:id><gtr:title>Association between polymorphisms of the dopamine receptor D2 and catechol-o-methyl transferase genes and cognitive function.</gtr:title><gtr:parentPublicationTitle>Behavior genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6c4e993e4fbbfa502e8e4bb3de0304b0"><gtr:id>6c4e993e4fbbfa502e8e4bb3de0304b0</gtr:id><gtr:otherNames>Bolton JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0001-8244</gtr:issn><gtr:outcomeId>MrfogADcNSS</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D5E9506-64CC-4B80-8505-41C94A8AEFC8</gtr:id><gtr:title>Prediction of outcome after moderate and severe traumatic brain injury: external validation of the International Mission on Prognosis and Analysis of Clinical Trials (IMPACT) and Corticoid Randomisation After Significant Head injury (CRASH) prognostic models.</gtr:title><gtr:parentPublicationTitle>Critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/58817ae986e78252e679b5980b439ab3"><gtr:id>58817ae986e78252e679b5980b439ab3</gtr:id><gtr:otherNames>Roozenbeek B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0090-3493</gtr:issn><gtr:outcomeId>pm_12896_26_22511138</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7736335C-34E6-4B83-86ED-A2243CE7278F</gtr:id><gtr:title>Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f67a36f4c44c4922a18eaf376974507b"><gtr:id>f67a36f4c44c4922a18eaf376974507b</gtr:id><gtr:otherNames>Whiteley WN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>pm_12896_26_23642343</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BEE13E6F-BC5A-4EB0-BFF9-5AA6C0BBF931</gtr:id><gtr:title>Screening for suicidality in cancer patients using Item 9 of the nine-item patient health questionnaire; does the item score predict who requires further assessment?</gtr:title><gtr:parentPublicationTitle>General hospital psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a3aabcaa9fd883d77d7401fb9ae5630"><gtr:id>5a3aabcaa9fd883d77d7401fb9ae5630</gtr:id><gtr:otherNames>Walker J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0163-8343</gtr:issn><gtr:outcomeId>tnC1qzA1zSu</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B037853-8C0F-4512-AD1E-22B311E9A661</gtr:id><gtr:title>A systematic review and individual patient data meta-analysis of prognostic factors for foot ulceration in people with diabetes: the international research collaboration for the prediction of diabetic foot ulcerations (PODUS).</gtr:title><gtr:parentPublicationTitle>Health technology assessment (Winchester, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7caf08ea521ae8777e689866dc68cf39"><gtr:id>7caf08ea521ae8777e689866dc68cf39</gtr:id><gtr:otherNames>Crawford F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1366-5278</gtr:issn><gtr:outcomeId>56af3efe58ea88.84226130</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>358F31E2-905A-42E3-A485-7E8C44AFA794</gtr:id><gtr:title>Improving the translational hit of experimental treatments in multiple sclerosis.</gtr:title><gtr:parentPublicationTitle>Multiple sclerosis (Houndmills, Basingstoke, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/afccff65ae6e6b0c0845b76d65cc6180"><gtr:id>afccff65ae6e6b0c0845b76d65cc6180</gtr:id><gtr:otherNames>Vesterinen HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1352-4585</gtr:issn><gtr:outcomeId>iQBAv5RrZfM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E8FDD0D8-737D-4907-B662-76D41B0EBA31</gtr:id><gtr:title>Recruiting South Asians to a lifestyle intervention trial: experiences and lessons from PODOSA (Prevention of Diabetes &amp;amp; Obesity in South Asians).</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/438e355888c23bc2cef769105af3c36f"><gtr:id>438e355888c23bc2cef769105af3c36f</gtr:id><gtr:otherNames>Douglas A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>p9MVG29qsCG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6D4F140D-F88B-4A25-A61B-9076F444F047</gtr:id><gtr:title>Thoughts of death and suicide reported by cancer patients who endorsed the &amp;quot;suicidal thoughts&amp;quot; item of the PHQ-9 during routine screening for depression.</gtr:title><gtr:parentPublicationTitle>Psychosomatics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a3aabcaa9fd883d77d7401fb9ae5630"><gtr:id>5a3aabcaa9fd883d77d7401fb9ae5630</gtr:id><gtr:otherNames>Walker J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0033-3182</gtr:issn><gtr:outcomeId>pm_12896_26_21907060</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>03C6430C-2802-42AB-9A50-D68F164701E2</gtr:id><gtr:title>European society of intensive care medicine study of therapeutic hypothermia (32-35 &amp;deg;C) for intracranial pressure reduction after traumatic brain injury (the Eurotherm3235Trial).</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f42d22bd69ad64632e7a81707795f01f"><gtr:id>f42d22bd69ad64632e7a81707795f01f</gtr:id><gtr:otherNames>Andrews PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>B1DNoDqan4n</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1145C120-66FE-4938-9F7F-E9162039E7BA</gtr:id><gtr:title>Effectiveness of intermittent pneumatic compression in reduction of risk of deep vein thrombosis in patients who have had a stroke (CLOTS 3): a multicentre randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2fee3f680ce8e0b59dd2603db0f2a316"><gtr:id>2fee3f680ce8e0b59dd2603db0f2a316</gtr:id><gtr:otherNames>CLOTS (Clots in Legs Or sTockings after Stroke) Trials Collaboration</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>pm_12896_26_23727163</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>941D4234-E017-4ED4-9AE7-B07E67A29648</gtr:id><gtr:title>Prevalence of depression in adults with cancer: a systematic review.</gtr:title><gtr:parentPublicationTitle>Annals of oncology : official journal of the European Society for Medical Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a3aabcaa9fd883d77d7401fb9ae5630"><gtr:id>5a3aabcaa9fd883d77d7401fb9ae5630</gtr:id><gtr:otherNames>Walker J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0923-7534</gtr:issn><gtr:outcomeId>pm_12896_26_23175625</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A7466FA-2CA1-4A5F-958E-58920FD9B6AA</gtr:id><gtr:title>Does intermittent pneumatic compression reduce the risk of post stroke deep vein thrombosis? The CLOTS 3 trial: statistical analysis plan.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8a64354cef682d91105e2c9e80246794"><gtr:id>8a64354cef682d91105e2c9e80246794</gtr:id><gtr:otherNames>Dennis M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>pm_12896_26_23497465</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A53A338D-F99F-4EC4-9159-D9B503D8DC29</gtr:id><gtr:title>Sputum matrix metalloproteinase-12 in patients with chronic obstructive pulmonary disease and asthma: relationship to disease severity.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3bbf8f8ec118b7d549d2590635bae18b"><gtr:id>3bbf8f8ec118b7d549d2590635bae18b</gtr:id><gtr:otherNames>Chaudhuri R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>pm_12896_26_22305682</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E9F8D897-20B7-47D5-A2C3-C3CCCCD231B1</gtr:id><gtr:title>Targeting recombinant tissue-type plasminogen activator in acute ischemic stroke based on risk of intracranial hemorrhage or poor functional outcome: an analysis of the third international stroke trial.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f67a36f4c44c4922a18eaf376974507b"><gtr:id>f67a36f4c44c4922a18eaf376974507b</gtr:id><gtr:otherNames>Whiteley WN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn><gtr:outcomeId>pm_540e15fe15f9dd31e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3CFF7F3E-BB5A-42D4-8C33-7B9E631929D2</gtr:id><gtr:title>Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/92c807dd74c086f13d2174d70fc9bf1c"><gtr:id>92c807dd74c086f13d2174d70fc9bf1c</gtr:id><gtr:otherNames>Marioni RE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>f43dS626t4e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A2796BAF-9FB3-41CB-9928-AC0F88FDE50B</gtr:id><gtr:title>Randomized comparison of uterine artery embolization (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): subanalysis of 5-year MRI findings.</gtr:title><gtr:parentPublicationTitle>Cardiovascular and interventional radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ffda20b1b5d0ae9889f9027ef6875d6"><gtr:id>2ffda20b1b5d0ae9889f9027ef6875d6</gtr:id><gtr:otherNames>Ananthakrishnan G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0174-1551</gtr:issn><gtr:outcomeId>doi_12896_012_0485_y</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1EBFE792-45DA-4EF4-89D0-6664AADAD872</gtr:id><gtr:title>Statistical approaches for evaluating surrogate outcomes in clinical trials: A systematic review.</gtr:title><gtr:parentPublicationTitle>Journal of biopharmaceutical statistics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b2d0d8cdc51a71e205c69845a6c18125"><gtr:id>b2d0d8cdc51a71e205c69845a6c18125</gtr:id><gtr:otherNames>Ensor H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1054-3406</gtr:issn><gtr:outcomeId>585d376d9a7551.12286887</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ECE0C49A-2F9A-4FF0-88C0-961161303C30</gtr:id><gtr:title>Telemonitoring-based service redesign for the management of uncontrolled hypertension (HITS): cost and cost-effectiveness analysis of a randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e001608f61b34f2514c1e65966480dc"><gtr:id>0e001608f61b34f2514c1e65966480dc</gtr:id><gtr:otherNames>Stoddart A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>543e9445d34116.27166874</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>71CE2DA9-171B-4B32-863D-D00DA7AA7AA5</gtr:id><gtr:title>The Glasgow Coma Scale at 40 years: standing the test of time.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd70628987fafd3caa35005492b42f0b"><gtr:id>bd70628987fafd3caa35005492b42f0b</gtr:id><gtr:otherNames>Teasdale G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>54524fe227a303.37894115</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>92D821C4-1083-43E2-B53F-704B0A5B0B60</gtr:id><gtr:title>Effects of short-term treatment with atorvastatin in smokers with asthma--a randomized controlled trial.</gtr:title><gtr:parentPublicationTitle>BMC pulmonary medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f1f944916fe452c1aabcdcb8eb5862ba"><gtr:id>f1f944916fe452c1aabcdcb8eb5862ba</gtr:id><gtr:otherNames>Braganza G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1471-2466</gtr:issn><gtr:outcomeId>pFPKw6BucAW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D80525A-EF6A-47EB-A295-5DD817347DD7</gtr:id><gtr:title>Symptoms 'unexplained by organic disease' in 1144 new neurology out-patients: how often does the diagnosis change at follow-up?</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89df86805aa041d4da8d635bbf45d7ca"><gtr:id>89df86805aa041d4da8d635bbf45d7ca</gtr:id><gtr:otherNames>Stone J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>5752DDACBB8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>748B97DD-13A7-4DB6-B7AD-551E9BF0D7B5</gtr:id><gtr:title>Guided self-help for functional (psychogenic) symptoms: a randomized controlled efficacy trial.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/af279763f6cdfe6575e4b958710f21ea"><gtr:id>af279763f6cdfe6575e4b958710f21ea</gtr:id><gtr:otherNames>Sharpe M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>GDSTXtK7syx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8051A432-EDCE-47C0-86CB-800755848FF5</gtr:id><gtr:title>Integrated collaborative care for major depression comorbid with a poor prognosis cancer (SMaRT Oncology-3): a multicentre randomised controlled trial in patients with lung cancer.</gtr:title><gtr:parentPublicationTitle>The Lancet. Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a3aabcaa9fd883d77d7401fb9ae5630"><gtr:id>5a3aabcaa9fd883d77d7401fb9ae5630</gtr:id><gtr:otherNames>Walker J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1470-2045</gtr:issn><gtr:outcomeId>545251eb5e1f24.55808367</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E5344B4D-7BE4-41D0-AFA9-9727D9FA0811</gtr:id><gtr:title>Sleep problems in cancer patients: prevalence and association with distress and pain.</gtr:title><gtr:parentPublicationTitle>Psycho-oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fc2a5ec38a278217b3bed88e037a7848"><gtr:id>fc2a5ec38a278217b3bed88e037a7848</gtr:id><gtr:otherNames>Sharma N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1057-9249</gtr:issn><gtr:outcomeId>pm_12896_26_21726015</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>04C5C790-902C-4BE5-A1EC-E2F28D1E5C0E</gtr:id><gtr:title>Hypothermia for Intracranial Hypertension after Traumatic Brain Injury.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f42d22bd69ad64632e7a81707795f01f"><gtr:id>f42d22bd69ad64632e7a81707795f01f</gtr:id><gtr:otherNames>Andrews PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>56af3efd6391d0.84203512</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9C49866B-D873-4682-B7DC-BC237BAE76ED</gtr:id><gtr:title>Associations between polymorphisms in five inflammation-related genes and cognitive ability in older persons.</gtr:title><gtr:parentPublicationTitle>Genes, brain, and behavior</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/92c807dd74c086f13d2174d70fc9bf1c"><gtr:id>92c807dd74c086f13d2174d70fc9bf1c</gtr:id><gtr:otherNames>Marioni RE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1601-183X</gtr:issn><gtr:outcomeId>cwbKsRqqELg</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1F2208B8-F865-4D57-B1C2-ACE52474A149</gtr:id><gtr:title>Relation between change in blood pressure in acute stroke and risk of early adverse events and poor outcome.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d5ee0623edd53b569cccc8391410d84"><gtr:id>9d5ee0623edd53b569cccc8391410d84</gtr:id><gtr:otherNames>Sandset EC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn><gtr:outcomeId>pm_12896_26_22627991</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0415A8F8-11EE-4E00-9984-B59AA0C1E773</gtr:id><gtr:title>The use of blood biomarkers to predict poor outcome after acute transient ischemic attack or ischemic stroke.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e0e5e9cd102979ad42c3c043c5c1088d"><gtr:id>e0e5e9cd102979ad42c3c043c5c1088d</gtr:id><gtr:otherNames>Whiteley W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn><gtr:outcomeId>pm_12896_26_22020034</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>69488444-963F-459C-A22F-29581044917E</gtr:id><gtr:title>Treatment of depression in people with lung cancer: a systematic review.</gtr:title><gtr:parentPublicationTitle>Lung cancer (Amsterdam, Netherlands)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a3aabcaa9fd883d77d7401fb9ae5630"><gtr:id>5a3aabcaa9fd883d77d7401fb9ae5630</gtr:id><gtr:otherNames>Walker J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0169-5002</gtr:issn><gtr:outcomeId>pm_12896_26_23102652</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0E7DA2B2-C844-48AB-8703-37B90A5F1C10</gtr:id><gtr:title>Patients repeatedly referred to secondary care with symptoms unexplained by organic disease: prevalence, characteristics and referral pattern.</gtr:title><gtr:parentPublicationTitle>Family practice</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/508b7ccc63d689c50b06fbeb53ec65d9"><gtr:id>508b7ccc63d689c50b06fbeb53ec65d9</gtr:id><gtr:otherNames>McGorm K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0263-2136</gtr:issn><gtr:outcomeId>AkLUo2LgyEf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14C592C1-D3D6-4A4B-A06D-B3ED48D09658</gtr:id><gtr:title>Scoring system to identify patients at high risk of oesophageal cancer.</gtr:title><gtr:parentPublicationTitle>The British journal of surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2f9a1817089dfb7e4b69f60c1ab77fdd"><gtr:id>2f9a1817089dfb7e4b69f60c1ab77fdd</gtr:id><gtr:otherNames>Rhatigan E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0007-1323</gtr:issn><gtr:outcomeId>aSNtBWRb4M6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>905D966F-C4F9-400C-89DD-1CFA143268FA</gtr:id><gtr:title>Spreading depolarisations and outcome after traumatic brain injury: a prospective observational study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/98798abc0534d344c26aa82ce21a3a1a"><gtr:id>98798abc0534d344c26aa82ce21a3a1a</gtr:id><gtr:otherNames>Hartings JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>CT9g1LaiyRv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1247CE48-445B-4F04-AA03-ECF2E9E736B9</gtr:id><gtr:title>The next step in understanding the prognosis of cerebral cavernous malformations.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/465202a0e76a70c877a9acff11c95c35"><gtr:id>465202a0e76a70c877a9acff11c95c35</gtr:id><gtr:otherNames>Al-Shahi Salman R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_12896_26_22302544</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1A3091FC-3A5B-48A6-8F5C-7030268B17F7</gtr:id><gtr:title>Erratum to: The International Stroke Trial database</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dd709aad3f5a6eca29e8d074bee23e6a"><gtr:id>dd709aad3f5a6eca29e8d074bee23e6a</gtr:id><gtr:otherNames>Sandercock P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>543e9446cc8dc8.54223592</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A157892F-EB1F-4F80-8D11-4AB691CCC6AC</gtr:id><gtr:title>Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a6d4944da6060d033e7b78eb9c8749e1"><gtr:id>a6d4944da6060d033e7b78eb9c8749e1</gtr:id><gtr:otherNames>Wardlaw JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>pm_12896_26_22632907</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F2A16045-E5A8-428D-AAC6-33AD1F10499D</gtr:id><gtr:title>Five-Year Mortality and Hospital Costs Associated with Surviving Intensive Care.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dfb032ea0c3f6c42b22b55ad8dfc324e"><gtr:id>dfb032ea0c3f6c42b22b55ad8dfc324e</gtr:id><gtr:otherNames>Lone NI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>56af3efce0b201.74005970</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D4C40AE4-6845-43F3-BDE6-4CF5675A4D68</gtr:id><gtr:title>Association of circulating inflammatory markers with recurrent vascular events after stroke: a prospective cohort study.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e0e5e9cd102979ad42c3c043c5c1088d"><gtr:id>e0e5e9cd102979ad42c3c043c5c1088d</gtr:id><gtr:otherNames>Whiteley W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn><gtr:outcomeId>RKbguugLLze</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E75D0E50-594A-49D7-B5E2-B632F361337B</gtr:id><gtr:title>Systematic review of observational research studying the long-term use of antithrombotic medicines following intracerebral hemorrhage.</gtr:title><gtr:parentPublicationTitle>Cardiovascular therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93069e26b264fca1219177db5f102541"><gtr:id>93069e26b264fca1219177db5f102541</gtr:id><gtr:otherNames>Flynn RW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1755-5914</gtr:issn><gtr:outcomeId>ZY8fqVELrHJ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>45304357-1672-4CD8-B5E4-95528CB42510</gtr:id><gtr:title>Can animal models of disease reliably inform human studies?</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa042f407adfdaf95faaccf5861beffd"><gtr:id>aa042f407adfdaf95faaccf5861beffd</gtr:id><gtr:otherNames>van der Worp HB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>cgCFHmqtPQB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D0882B64-B3E2-496B-AE77-4112EA03E3EC</gtr:id><gtr:title>A concerted appeal for international cooperation in preclinical stroke research.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c567aa13eb0f56711fdf8d1d2bb16e63"><gtr:id>c567aa13eb0f56711fdf8d1d2bb16e63</gtr:id><gtr:otherNames>Dirnagl U</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn><gtr:outcomeId>543e94463ad743.71105349</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>55E80584-C8B2-457E-A362-E8CD06D2A7F2</gtr:id><gtr:title>Arterial Obstruction on Computed Tomographic or Magnetic Resonance Angiography and Response to Intravenous Thrombolytics in Ischemic Stroke.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6e8f84cffa8d60c2e0b79feeafd6061b"><gtr:id>6e8f84cffa8d60c2e0b79feeafd6061b</gtr:id><gtr:otherNames>Mair G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn><gtr:outcomeId>5a7320d9804a91.42700643</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>525FC948-F679-4CD7-BC73-76BEFB9C9C42</gtr:id><gtr:title>Hydrogel-coated coils versus bare platinum coils for the endovascular treatment of intracranial aneurysms (HELPS): a randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa55345414f4e4e5dcbffe63fe86c4df"><gtr:id>fa55345414f4e4e5dcbffe63fe86c4df</gtr:id><gtr:otherNames>White PM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>SXZ5kDUDNtu</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1620339F-3D40-407D-A9F0-F29EF6A6E93C</gtr:id><gtr:title>A rehabilitation intervention to promote physical recovery following intensive care: a detailed description of construct development, rationale and content together with proposed taxonomy to capture processes in a randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5ff7da8c86331add52ac669bf9d30097"><gtr:id>5ff7da8c86331add52ac669bf9d30097</gtr:id><gtr:otherNames>Ramsay P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>545251eb878d63.24258048</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A4979F7-E96B-496E-BC5E-00FB421C65CE</gtr:id><gtr:title>Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial.</gtr:title><gtr:parentPublicationTitle>JAMA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a07b16b8b420279616eb1441faac88ea"><gtr:id>a07b16b8b420279616eb1441faac88ea</gtr:id><gtr:otherNames>Fowkes FG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0098-7484</gtr:issn><gtr:outcomeId>jUJpPqxj4ov</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B40570AF-5804-47CA-8F46-3C27AB475BDF</gtr:id><gtr:title>Sliding dichotomy compared with fixed dichotomization of ordinal outcome scales in subarachnoid hemorrhage trials.</gtr:title><gtr:parentPublicationTitle>Journal of neurosurgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/66a84abf0adc4d6fa39ce90cff15ba0b"><gtr:id>66a84abf0adc4d6fa39ce90cff15ba0b</gtr:id><gtr:otherNames>Ilodigwe D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-3085</gtr:issn><gtr:outcomeId>pm_12896_26_23039145</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B66B76D9-1567-4A8D-9E52-8F9DC4DC4E4F</gtr:id><gtr:title>Pain, depression, and fatigue as a symptom cluster in advanced cancer.</gtr:title><gtr:parentPublicationTitle>Journal of pain and symptom management</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9a2fd8e1979cef419f7d26aa5f2109fd"><gtr:id>9a2fd8e1979cef419f7d26aa5f2109fd</gtr:id><gtr:otherNames>Laird BJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0885-3924</gtr:issn><gtr:outcomeId>gkxiQUnEgy5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F4395F3E-D3B5-422D-8F0E-6A053F299660</gtr:id><gtr:title>Study of therapeutic hypothermia (32 to 35&amp;deg;C) for intracranial pressure reduction after traumatic brain injury (the Eurotherm3235Trial): outcome of the pilot phase of the trial.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f42d22bd69ad64632e7a81707795f01f"><gtr:id>f42d22bd69ad64632e7a81707795f01f</gtr:id><gtr:otherNames>Andrews PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>543e94476c3149.09334213</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>69D738C0-D692-4249-88F7-4AC76E7F5436</gtr:id><gtr:title>Early prognosis in traumatic brain injury: from prophecies to predictions.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0d1d81d86ec3031057d15ddf62f6005b"><gtr:id>0d1d81d86ec3031057d15ddf62f6005b</gtr:id><gtr:otherNames>Lingsma HF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>hfJwbSBhjYf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0B6CFFED-D3DA-4801-A734-7AEDD1063D81</gtr:id><gtr:title>Time dependence of biomarkers: non-proportional effects of immunohistochemical panels predicting relapse risk in early breast cancer.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3d663a5854305f79599d192de10e774a"><gtr:id>3d663a5854305f79599d192de10e774a</gtr:id><gtr:otherNames>Stephen J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn><gtr:outcomeId>56af3f0090b702.92631070</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4EE46DB1-BA85-407D-8B68-4C9947AF62C2</gtr:id><gtr:title>Prognostic value of major extracranial injury in traumatic brain injury: an individual patient data meta-analysis in 39,274 patients.</gtr:title><gtr:parentPublicationTitle>Neurosurgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/052930c3f219c8a5cf0ec7a6a98d1f86"><gtr:id>052930c3f219c8a5cf0ec7a6a98d1f86</gtr:id><gtr:otherNames>van Leeuwen N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0148-396X</gtr:issn><gtr:outcomeId>nbBmSuGTGwk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>46D9B2B9-299D-4173-961A-45D160E7BE02</gtr:id><gtr:title>Baseline characteristics and statistical power in randomized controlled trials: Selection, prognostic targeting, or covariate adjustment?*</gtr:title><gtr:parentPublicationTitle>Critical Care Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/58817ae986e78252e679b5980b439ab3"><gtr:id>58817ae986e78252e679b5980b439ab3</gtr:id><gtr:otherNames>Roozenbeek B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:outcomeId>doi_55f9459450fddf7a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>126E086A-5F1C-41BF-8E94-6C6EAEBF5E6C</gtr:id><gtr:title>The HSCL-20: one questionnaire, two versions.</gtr:title><gtr:parentPublicationTitle>Journal of psychosomatic research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a3aabcaa9fd883d77d7401fb9ae5630"><gtr:id>5a3aabcaa9fd883d77d7401fb9ae5630</gtr:id><gtr:otherNames>Walker J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-3999</gtr:issn><gtr:outcomeId>buxvigB6D3f</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>563FD745-DCB7-4794-847D-19F99FFFF6B1</gtr:id><gtr:title>Edaravone improves functional and structural outcomes in animal models of focal cerebral ischemia: a systematic review.</gtr:title><gtr:parentPublicationTitle>International journal of stroke : official journal of the International Stroke Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d93e0d9984e7d52bb28236d6ce868b44"><gtr:id>d93e0d9984e7d52bb28236d6ce868b44</gtr:id><gtr:otherNames>Wu S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1747-4930</gtr:issn><gtr:outcomeId>doi_12896__ijs_12163</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB3DB394-5EEC-48C2-A677-223B30830663</gtr:id><gtr:title>Integrated collaborative care for comorbid major depression in patients with cancer (SMaRT Oncology-2): a multicentre randomised controlled effectiveness trial.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/af279763f6cdfe6575e4b958710f21ea"><gtr:id>af279763f6cdfe6575e4b958710f21ea</gtr:id><gtr:otherNames>Sharpe M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>545250eeb21818.14957293</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0EE35A55-10D2-4C80-AF2C-5CB4597C8DFE</gtr:id><gtr:title>Measuring improvement in depression in cancer patients: a 50% drop on the self-rated SCL-20 compared with a diagnostic interview.</gtr:title><gtr:parentPublicationTitle>General hospital psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fcfe5fea0c084750c4184210cf1682a7"><gtr:id>fcfe5fea0c084750c4184210cf1682a7</gtr:id><gtr:otherNames>O'Connor M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0163-8343</gtr:issn><gtr:outcomeId>SzY1Ki83TWn</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0800803</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>208C592B-C1B7-4E87-A19A-04E8D9458E50</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>6.9  Resources and infrastructure (evaluation of treatments)</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>90487A08-C473-4CEB-B6D9-011A74AD06CF</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>8.4  Research design and methodologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>